HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
A M Carella Selected Research
A M Carella Research Topics
Disease
5
Neoplasms (Cancer)
08/2012 - 02/2000
4
BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
08/2012 - 01/2000
4
Graft vs Host Disease (Graft-Versus-Host Disease)
06/2011 - 02/2000
3
Hodgkin Disease (Hodgkin's Disease)
08/2018 - 12/2000
3
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
07/2017 - 03/2000
3
Multiple Myeloma
01/2016 - 10/2011
3
Leukemia
06/2010 - 01/2000
2
Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
12/2014 - 02/2014
2
Breast Neoplasms (Breast Cancer)
10/2007 - 10/2007
1
Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic)
07/2017
1
Myelodysplastic Syndromes (Myelodysplastic Syndrome)
07/2017
1
Neutropenia
03/2013
1
Anemia
03/2013
1
Infections
03/2013
1
Thrombotic Thrombocytopenic Purpura
06/2008
1
Insulin Resistance
09/2007
1
Weight Gain
09/2007
1
Weight Loss (Weight Reduction)
09/2007
1
Dyslipidemias (Dyslipidemia)
09/2007
1
Non-Hodgkin Lymphoma (Lymphosarcoma)
12/2000
1
Lymphoma (Lymphomas)
12/2000
1
Body Weight (Weight, Body)
06/2000
1
Inborn Genetic Diseases (Disease, Hereditary)
03/2000
1
Hematologic Neoplasms (Hematological Malignancy)
02/2000
Drug/Important Bio-Agent (IBA)
2
Rituximab (Mabthera)
FDA Link
12/2014 - 06/2008
2
Lenalidomide (CC 5013)
FDA Link
03/2013 - 10/2011
2
fludarabine
IBA
01/2001 - 12/2000
1
Brentuximab Vedotin
IBA
08/2018
1
Immune Checkpoint Inhibitors
IBA
08/2018
1
Azacitidine (5 Azacytidine)
FDA Link
07/2017
1
Bortezomib (Velcade)
FDA Link
01/2016
1
Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)
FDA Link
02/2014
1
Melphalan (Alkeran)
FDA Link
Generic
03/2013
1
Clarithromycin (Biaxin)
FDA Link
Generic
08/2012
1
Tyrosine Kinase Inhibitors
IBA
08/2012
1
Monoclonal Antibodies
IBA
06/2011
1
Phosphotransferases (Kinase)
IBA
06/2010
1
Fibric Acids (Fibrates)
IBA
09/2007
1
Aldosterone
IBA
09/2007
1
Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)
IBA
09/2007
1
Antihypertensive Agents (Antihypertensives)
IBA
09/2007
1
Calcium Channel Blockers (Blockers, Calcium Channel)
IBA
09/2007
1
Diuretics
IBA
09/2007
1
Indapamide
FDA Link
Generic
09/2007
1
Lipids
IBA
09/2007
1
Metformin (Glucophage)
FDA Link
Generic
09/2007
1
Sodium
IBA
09/2007
1
Omega-3 Fatty Acids (Omega 3 Fatty Acids)
IBA
09/2007
1
Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)
IBA
09/2007
1
Anti-Obesity Agents (Antiobesity Drugs)
IBA
09/2007
1
Acarbose
FDA Link
Generic
09/2007
1
Thiazolidinediones
IBA
09/2007
1
Angiotensin Receptor Antagonists
IBA
09/2007
1
Alemtuzumab (Campath)
FDA Link
01/2004
1
Steroids
IBA
01/2004
1
Cytarabine (Cytosar-U)
FDA Link
Generic
01/2001
1
Granulocyte Colony-Stimulating Factor (G-CSF)
IBA
01/2001
1
Ice
IBA
01/2001
1
Hydroxyurea (Hydrea)
FDA Link
Generic
01/2001
1
Methotrexate (Mexate)
FDA Link
Generic
12/2000
1
Cyclophosphamide (Cytoxan)
FDA Link
Generic
12/2000
1
Cyclosporine (Ciclosporin)
FDA Link
Generic
12/2000
1
roquinimex
IBA
06/2000
1
Biological Products
IBA
03/2000
Therapy/Procedure
5
Therapeutics
08/2018 - 02/2000
5
Autologous Transplantation
04/2015 - 01/2000
5
Homologous Transplantation
06/2011 - 02/2000
3
Stem Cell Transplantation
07/2017 - 02/2000
3
Hematopoietic Stem Cell Transplantation
06/2011 - 03/2000
2
Salvage Therapy
11/2001 - 01/2001
1
Aftercare (After-Treatment)
07/2017
1
Hematopoietic Stem Cell Mobilization
10/2011
1
Bariatric Surgery
09/2007
1
Drug Therapy (Chemotherapy)
12/2000